PMID- 27922865 OWN - NLM STAT- MEDLINE DCOM- 20170314 LR - 20191210 IS - 1536-0229 (Electronic) IS - 0363-9762 (Linking) VI - 42 IP - 2 DP - 2017 Feb TI - Additional Value of Early-Phase 18F-FP-CIT PET Image for Differential Diagnosis of Atypical Parkinsonism. PG - e80-e87 LID - 10.1097/RLU.0000000000001474 [doi] AB - PURPOSE: Regional cerebral perfusion is coupled to metabolism in general. Early perfusion dominant imaging using F-FP-CIT PET (pCIT) may provide complementary information to delayed dopamine transporter dominant images. We investigated the ability of pCIT to differentiate atypical Parkinson disorder from Parkinson disease (PD) compared to FDG and the image quality for optimizing the acquisition time. METHODS: Sixty-seven subjects [PD, 23 subjects; multiple system atrophy-cerebellar type (MSA-C), 27 subjects; MSA-Parkinson type (MSA-P), 12 subjects; and progressive supranuclear palsy (PSP), 5 subjects] underwent F-FP-CIT and FDG PET. Using dynamic PET data acquired during the first 10 minutes after F-FP-CIT administration, we generated potential perfusion images of 0 to 5 (pCIT-5m), 0 to 7 (pCIT-7m), and 0 to 10 (pCIT-10m) minutes. We compared regional uptake between groups in pCIT and FDG images and image quality among pCIT images using visual, quantitative, or statistical parametric mapping analyses. RESULTS: Regional cerebral uptake of pCITs correlated well to that of the FDG images (R > 0.5, all). Multiple system atrophy-cerebellar type and MSA-P groups show different regional uptake patterns compared with PD group on pCITs in quantitative and statistical parametric mapping analyses, analogous to FDG images, but not in the PSP group. In visual analysis, concordance rates between each pCIT and FDG image were high (92.3%-96.0%, regional; 86.2%-93.1%, diagnostic), and there was no significant difference among pCITs. However, pCIT-10m discriminated PSP better than others and showed higher signal-to-noise ratio (P = 0.001). CONCLUSION: F-FP-CIT PETs with the first 10 minutes could be useful for the differential diagnosis of atypical Parkinson disorder by providing complementary FDG-like information to the dopamine transporter binding on late-phase FP-CIT images. FAU - Jin, Soyoung AU - Jin S AD - From the *Department of Nuclear Medicine, Nowon Eulji Medical Center, Eulji University, Seoul, Korea; and Departments of daggerNuclear Medicine, and double daggerNeurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. FAU - Oh, Minyoung AU - Oh M FAU - Oh, Seung Jun AU - Oh SJ FAU - Oh, Jungsu S AU - Oh JS FAU - Lee, Sang Ju AU - Lee SJ FAU - Chung, Sun Ju AU - Chung SJ FAU - Kim, Jae Seung AU - Kim JS LA - eng PT - Evaluation Study PT - Journal Article PL - United States TA - Clin Nucl Med JT - Clinical nuclear medicine JID - 7611109 RN - 0 (Radiopharmaceuticals) RN - 0 (Tropanes) RN - 155797-99-2 (2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane) SB - IM MH - Aged MH - Diagnosis, Differential MH - Female MH - Humans MH - Male MH - Middle Aged MH - Parkinson Disease/*diagnostic imaging MH - *Positron-Emission Tomography MH - *Radiopharmaceuticals MH - Sensitivity and Specificity MH - *Tropanes EDAT- 2016/12/07 06:00 MHDA- 2017/03/16 06:00 CRDT- 2016/12/07 06:00 PHST- 2016/12/07 06:00 [pubmed] PHST- 2017/03/16 06:00 [medline] PHST- 2016/12/07 06:00 [entrez] AID - 10.1097/RLU.0000000000001474 [doi] PST - ppublish SO - Clin Nucl Med. 2017 Feb;42(2):e80-e87. doi: 10.1097/RLU.0000000000001474.